Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Morningstar, Inc. to Announce Second-Quarter 2025 Financial Results on July 30
-
BXP to Release Second Quarter 2025 Financial Results on July 29, 2025
-
Progress Software Announces Second Quarter 2025 Financial Results
-
CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger
-
Jumia Opens New Warehouse in Egypt to Boost Logistics, Job Creation, and Digital Economy
-
ELV DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Elevance Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important July 11 Deadline in Securities Class Action
-
F3 Issues Shares for Interest Debt Settlement
-
Feeding America statement on reconciliation legislation being considered by the Senate
-
Findell Capital Reiterates Desire for Compromise at Oportun Financial and Issues Statement on Behalf of Scott Parker
-
Delek Logistics Partners, LP Announces the Closing of Upsized Offering of $700 Million of Senior Notes
-
Pivot Bio Announces Inaugural Investor & Innovation Day
-
First Trust Enhanced Equity Income Fund Issues Notice Regarding June 2025 Distribution
-
Bone Biologics Announces Closing of $5.0 Million Public Offering
-
First Trust Advisors L.P. Announces Distributions for Exchange-Traded Funds
-
PetVivo Reports Fiscal 2025 Results
-
Blue Gold Limited Announces Acquisition Initiatives Following Successful Listing on Nasdaq
-
Middlesex Water Files for Rate Request
-
How a Few Days in Nature Can Be Life-Changing for Teens
-
SB Financial Group Joins Russell 3000 Index
-
CNB Financial Corporation and ESSA Bancorp, Inc. Receive Bank Regulatory Approvals for Merger
-
The Oncology Institute and SilverSummit Healthplan Partner to Provide Oncology Care to Over 80,000 Medicaid Members in Nevada
-
NodeOps Network $NODE Token Generation Event Sells Out in Minutes via Binance Wallet, Debuts Across Top Global Exchanges
-
WASTE CONNECTIONS ANNOUNCES DATES FOR SECOND QUARTER 2025 EARNINGS RELEASE
-
Halozyme Therapeutics Added to Russell 1000® Index
-
APPLICATIONS OPEN FOR NEXT TEN N-SISS: FELLOWS
-
Boeing Announces Chief Financial Officer Transition Plan
-
Ultra Clean Announces Retirement of Bill Bentinck, President of Services Division
-
Cisco & Wells Fargo to Host Silicon One Tech Talk
-
Fannie Mae Releases May 2025 Monthly Summary
-
Pathfinder Bancorp, Inc. Declares Dividend
-
Industry First -- Supermicro Systems Certified by Intel for an Immersion Cooling Solution
-
Olin and K2 Announce Strategic Expansion of Bleach Distribution Partnership in California and the Western United States
-
Ameresco to Announce Second Quarter 2025 Financial Results on August 4, 2025
-
FrontView REIT Appoints Pierre Revol, Seasoned Industry Executive, as Chief Financial Officer
-
RGP Announces Board Refreshment
-
Neurocrine Biosciences Announces Initiation of Phase 1 Clinical Study Evaluating NBIP-01435, a Long-Acting Corticotropin-Releasing Factor Type 1 Receptor Antagonist
-
BGC Group Updates its Outlook for the Second Quarter of 2025
-
LogProstyle Inc. Announces Results of the 2025 Annual General Meeting of Shareholders
-
SkyWater Completes Acquisition of Fab 25, Expanding U.S. Pure-Play Foundry Capacity for Critical Semiconductor Technologies
-
AdaptHealth Corp. Closes Transaction to Dispose of Certain Home Infusion Assets and Reduces Debt
-
Agree Realty Announces Second Quarter 2025 Earnings Release Date and Conference Call Information
-
Lumen Technologies Advances Financial Strategy to Support AI-Era Infrastructure Growth
-
Lineage to Report Second-Quarter 2025 Financial Results on August 6, 2025
-
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
-
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
-
Yorkville Acquisition Corp. Announces Closing of $172,500,000 Initial Public Offering, Including Full Exercise of Underwriters’ Over-Allotment Option
-
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Progress Software Acquires Nuclia, an Innovator in Agentic RAG AI Technology
-
Zeo Energy Corp. Joins Russell Microcap® Index
